Volodymyr (Vlad) Nikolenko, PhD, MBA
Dr. Nikolenko joined Royalty Pharma in 2017. Previously, Dr. Nikolenko was an equity research associate on the Evercore ISI biotech and pharma team. Mr. Nikolenko also previously was a senior financial analyst at Merck and a senior portfolio analyst at Columbia Technology Ventures. Dr. Nikolenko has a BS/MS from Moscow Institute of Physics and Technology, an MBA from Columbia University, and a PhD in neuroscience from Columbia University.